Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|9|4|392-398
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.4, 2009-12, pp. : 392-398
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus
Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. :
Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus
Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. :
Rosiglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus
Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. :
Glimepiride: A Review of its Use in the Management of Type 2 Diabetes Mellitus
Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. :